A Phase 2 interventional study of SakuraBead for knee osteoarthritis

Study Description

Comparing SakuraBead genicular artery embolization with corticosteroid injection for knee osteoarthritis pain

Study Details

Registry ID:

NCT06550024

Conditions:

Osteo Arthritis Knee, Joint Diseases, Musculoskeletal Diseases, Rheumatic Diseases, Arthritis, Osteoarthritis

Phase:

Not Applicable

Target Enrollment:

89 participants

Start Date:

November 28, 2024

Age Range:

40–79 years

Healthy Volunteers:

No

Study Locations (10 sites)

• Royal Berkshire NHS Foundation Trust
  ReadingUnited Kingdom, United Kingdom
• Bokhua Memorial Cardiovascular Center
  TbilisiGeorgia, Georgia
• Nano Medical Clinic
  TashkentUzbekistan, Uzbekistan
• Nano Medical Clinic
  Tashkent, UzbekistanUzbekistan, Uzbekistan
• IR Centers
  Raleigh, North CarolinaUnited States, United States
• IR Centers
  Leesburg, VirginiaUnited States, United States
• Advanced Vascular Institute
  Panama City, FloridaUnited States, United States
• University of Alabama Medicine
  Birmingham, AlabamaUnited States, United States
• Harbor UCLA Medical Center
  Torrance, CaliforniaUnited States, United States
• Orthopedic and Fracture Specialists (O&FS)
  Beaverton, OregonUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →